Maurene Viele

2.0k total citations
31 papers, 1.4k citations indexed

About

Maurene Viele is a scholar working on Hematology, Biochemistry and Physiology. According to data from OpenAlex, Maurene Viele has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Biochemistry and 7 papers in Physiology. Recurrent topics in Maurene Viele's work include Blood transfusion and management (11 papers), Blood groups and transfusion (7 papers) and Erythrocyte Function and Pathophysiology (4 papers). Maurene Viele is often cited by papers focused on Blood transfusion and management (11 papers), Blood groups and transfusion (7 papers) and Erythrocyte Function and Pathophysiology (4 papers). Maurene Viele collaborates with scholars based in United States, Poland and Japan. Maurene Viele's co-authors include Richard B. Weiskopf, Pearl Toy, John Feiner, Harriet W. Hopf, Jessica J. Watson, Lawrence T. Goodnough, Jeremy A. Lieberman, Scott D. Kelley, Jacqueline M. Leung and Mariam Noorani and has published in prestigious journals such as Hepatology, Anesthesiology and Urology.

In The Last Decade

Maurene Viele

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurene Viele United States 21 619 452 346 225 187 31 1.4k
Chantal R. Harrison United States 11 451 0.7× 375 0.8× 216 0.6× 167 0.7× 157 0.8× 26 1.1k
Mark H. Yazer United States 20 586 0.9× 710 1.6× 318 0.9× 563 2.5× 73 0.4× 80 1.5k
T. L. Simon United States 18 495 0.8× 319 0.7× 367 1.1× 127 0.6× 129 0.7× 34 1.2k
R. G. Strauss United States 20 423 0.7× 303 0.7× 409 1.2× 124 0.6× 109 0.6× 39 1.2k
D. OʼShaughnessy United Kingdom 15 456 0.7× 404 0.9× 417 1.2× 117 0.5× 89 0.5× 28 1.3k
Brett L. Houston Canada 13 84 0.1× 326 0.7× 186 0.5× 127 0.6× 303 1.6× 38 1.3k
Hemang Yadav United States 18 159 0.3× 229 0.5× 116 0.3× 142 0.6× 324 1.7× 64 1.2k
Mary F. Nelson United States 19 222 0.4× 931 2.1× 139 0.4× 857 3.8× 221 1.2× 30 1.4k
W. K. Vaughn United States 14 224 0.4× 137 0.3× 68 0.2× 60 0.3× 143 0.8× 32 1.2k
Bettina Leschnik Austria 19 51 0.1× 77 0.2× 526 1.5× 69 0.3× 92 0.5× 56 1.1k

Countries citing papers authored by Maurene Viele

Since Specialization
Citations

This map shows the geographic impact of Maurene Viele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurene Viele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurene Viele more than expected).

Fields of papers citing papers by Maurene Viele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurene Viele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurene Viele. The network helps show where Maurene Viele may publish in the future.

Co-authorship network of co-authors of Maurene Viele

This figure shows the co-authorship network connecting the top 25 collaborators of Maurene Viele. A scholar is included among the top collaborators of Maurene Viele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurene Viele. Maurene Viele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fontaine, Magali J., et al.. (2012). How we treat: risk mitigation for ABO‐incompatible plasma in plateletpheresis products. Transfusion. 52(10). 2081–2085. 27 indexed citations
2.
McClain, Colt M., et al.. (2012). Blood ordering from the operating room: turnaround time as a quality indicator. Transfusion. 53(1). 41–48. 11 indexed citations
3.
Feiner, John, Heather Finlay-Morreale, Pearl Toy, et al.. (2011). High Oxygen Partial Pressure Decreases Anemia-induced Heart Rate Increase Equivalent to Transfusion. Anesthesiology. 115(3). 492–498. 21 indexed citations
4.
Goodnough, Lawrence T., et al.. (2011). How we treat: transfusion medicine support of obstetric services. Transfusion. 51(12). 2540–2548. 34 indexed citations
5.
Fontaine, Magali J., Ge Chen, Susan A. Galel, et al.. (2011). Complement (C1q) fixing solid‐phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. Transfusion. 51(12). 2611–2618. 27 indexed citations
6.
Goodnough, Lawrence T., et al.. (2010). Quality management in the transfusion service: case studies in process improvement. Transfusion. 51(3). 600–609. 11 indexed citations
7.
Fontaine, Magali J., et al.. (2010). Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV‐seronegative blood inventory. Transfusion. 50(8). 1685–1689. 4 indexed citations
8.
Goodnough, Lawrence T., et al.. (2009). Implementation of a two‐specimen requirement for verification of ABO/Rh for blood transfusion. Transfusion. 49(7). 1321–1328. 28 indexed citations
9.
Wong, Wendy, Jason D. Merker, Christine Nguyen, et al.. (2007). Cold agglutinin syndrome in pediatric liver transplant recipients. Pediatric Transplantation. 11(8). 931–936. 17 indexed citations
10.
Burtelow, Matthew A., et al.. (2007). How we treat: management of life‐threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 47(9). 1564–1572. 101 indexed citations
11.
Rios, Jorge A., Julie Hambleton, Maurene Viele, et al.. (2006). Viability of red cells prepared with S‐303 pathogen inactivation treatment. Transfusion. 46(10). 1778–1786. 22 indexed citations
12.
Weiskopf, Richard B., John Feiner, Harriet W. Hopf, et al.. (2002). Oxygen Reverses Deficits of Cognitive Function and Memory and Increased Heart Rate Induced by Acute Severe Isovolemic Anemia. Anesthesiology. 96(4). 871–877. 108 indexed citations
13.
Weiskopf, Richard B., Joel H. Kramer, Maurene Viele, et al.. (2001). Abnormal Serum Sodium and Chloride Concentrations May Contribute to Cognitive Dysfunction during Severe Isovolemic Anemia. Anesthesiology. 94(4). 716–716. 1 indexed citations
14.
Toy, Pearl, et al.. (2000). Fatigue during acute isovolemic anemiain healthy, resting humans. Transfusion. 40(4). 457–460. 47 indexed citations
15.
Weiskopf, Richard B., Joel H. Kramer, Maurene Viele, et al.. (2000). Acute Severe Isovolemic Anemia Impairs Cognitive Function and Memory in Humans. Anesthesiology. 92(6). 1646–1652. 163 indexed citations
16.
Leung, Jacqueline M., Richard B. Weiskopf, John Feiner, et al.. (2000). Electrocardiographic ST-segment Changes during Acute, Severe Isovolemic Hemodilution in Humans. Anesthesiology. 93(4). 1004–1010. 90 indexed citations
17.
Stoller, Marshall L., Keith L. Lee, Bradley F. Schwartz, & Maurene Viele. (1999). Autologous blood use in percutaneous nephrolithotomy. Urology. 54(3). 444–449. 8 indexed citations
18.
Horn, Biljana, et al.. (1999). Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplantation. 24(9). 1009–1013. 51 indexed citations
19.
McHugh, Thomas M., et al.. (1997). The sensitive detection and quantitation of antibody to HVC by using a microsphere-based immunoassay and flow cytometry. Cytometry. 29(2). 106–112. 20 indexed citations
20.
Viele, Maurene & Richard B. Weiskopf. (1994). What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion. 34(5). 396–401. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026